Mavrilimumab for severe COVID-19
- PMID: 33521661
- PMCID: PMC7833724
- DOI: 10.1016/S2665-9913(20)30306-4
Mavrilimumab for severe COVID-19
References
-
- Dawson NV, Weiss R. Dichotomizing continuous variables in statistical analysis: a practice to avoid. Med Decis Making. 2012;32:225–226. - PubMed
LinkOut - more resources
Full Text Sources